Cell Reports Medicine

981 papers and 14.3k indexed citations i.

About

The 981 papers published in Cell Reports Medicine in the last decades have received a total of 14.3k indexed citations. Papers published in Cell Reports Medicine usually cover Molecular Biology (324 papers), Oncology (243 papers) and Immunology (236 papers) specifically the topics of Immune Cell Function and Interaction (84 papers), SARS-CoV-2 and COVID-19 Research (80 papers) and Cancer Immunotherapy and Biomarkers (74 papers). The most active scholars publishing in Cell Reports Medicine are Joaquı́n M. Espinosa, Allison J. Greaney, Jesse D. Bloom, Adam S. Dingens, Tyler N. Starr, Royce A. Wilkinson, Artem Nemudryi, Tanner Wiegand, Blake Wiedenheft and Anna Nemudraia.

In The Last Decade

Fields of papers published in Cell Reports Medicine

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Cell Reports Medicine. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Cell Reports Medicine

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Cell Reports Medicine. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Cell Reports Medicine with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025